Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

J&J: Strong sales growth in McNeil's Viactiv chewable calcium supplements was "substantially offset" by declines in adult analgesics, Imodium franchise during Q3, J&J reports in 1quarterly release and analysts call Oct. 15. Tylenol, Motrin marketer says Q3 adult analgesic sales compared unfavorably to year-ago period, "when retail inventories were built in anticipation of the fourth quarter flu season. Retailers are being more conservative this year and not stocking in similar fashion," according to J&J VP-Investor Relations Helen Short. Imodium also suffered in comparison to year-ago quarter, when Imodium Advanced caplets launched. McNeil worldwide sales rose a slight 1% to $448 mil. for the quarter, with U.S. sales gaining 3% to $387 mil. and international sales dropping 12% to $61 mil...
Advertisement

Related Content

Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004
Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004
Novartis Triaminic Allerchews With Loratadine Slated To Launch In 2004

Topics

Advertisement
UsernamePublicRestriction

Register

PS094685

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel